"Cumulus, aided by an extremely experienced and capable team, is innovating not only in the science, but in the entire process of how drugs are moved from discovery to later stage clinical trials. We are really pleased to be helping them achieve their ambitions and shine a spotlight on Scotland’s drug discovery capabilities."
Key Information
Key Mission
Harnessing Innovation
Amount Invested
£6m
Location
Edinburgh
Co-funders
Eos Advisory
Alignment to the United Nation's Sustainable Development Goals
All of the investments the Bank makes support the UN's Sustainable Development Goals. This investment supports the goals below:
Image
Goal 3
Good Health and Well-being
Image
Goal 8
Decent Work and Economic Growth
Image
Goal 9
Industry, Innovation and Infrastructure
Key quote
Founder and CEO Dr Clare Wareing said: "Oncology remains a vast and important area of scientific and clinical research.
“The ultimate goal is to increase the success rates at the vital phase III end of clinical testing, which currently remains at below 50%.
“The support from the Scottish National Investment Bank means we can both support our existing companies, expand our portfolio and continue to develop the next generation of cancer therapies."
